genOway maintains its activities during the COVID-19 pandemic

Covid-19 Pandemic

Since the beginning of the COVID-19 pandemic, we at genOway have deployed a robust plan to maintain the continuity of our activities, while guaranteeing the safety of our employees and communities.

We operate in North America, Europe and Asia, and as such, we follow restrictions imposed by French authorities as well as those by governments of countries we work with.

Our customers have always been at the heart of our priorities. Together, we determine your needs to provide you with the best possible solutions for you to pursue your studies.

We can also count on our solid and long-term relationships with our partner-suppliers to ensure our high standards of production and service. However, like many other biotechnology companies worldwide, we may experience production delays or shipment limitations due to temporary governmental restrictions. Should this apply to one of your projects, we will quickly get in touch with you to discuss alternatives, including, among others:

  • Maintaining backup colonies, which are housed and bred at Charles River’s facilities
  • Conducting more validation studies on your mouse, rat or cell lines in our laboratories, an opportunity that allows you to receive your model with an expanded set of validation data

Please rest assured of our whole team's total commitment to bringing your project to a successful execution and completion.

Alexandre Fraichard and the entire genOway team